Press releaseGlobe Newswire
GH Research
GHRS · NASDAQ
$19.17+$0.885 (+4.84%)TodayMarket closed ·
Prev close $18.28
Latest news
- Press releasePRNewswire
A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening
- Press releasePRNewswire
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
- NewsVandana Singh
Why Is GH Research Stock Trading Higher on Thursday?
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
- Press releasePRNewswire
A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
- NewsAvi Kapoor
These Analysts Revise Their Forecasts On GH Research After Q1 Results
- News
Earnings Scheduled For May 14, 2026
- Press releaseGlobe Newswire
GH Research Reports First Quarter 2026 Financial Results and Provides Business Update
- News
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
- Press releaseGlobe Newswire
GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness
- NewsNamrata Sen
Enveric BioSciences Surges Over 90%, Other Psychedelic Stocks Soar In Monday Pre-Market: What's Going On?
- Press releasePRNewswire
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions
- Press releasePRNewswire
Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments
- NewsAvi Kapoor
Dow Jumps 800 Points; ISM Manufacturing PMI Falls In December
- NewsAvi Kapoor
Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday
- NewsAvi Kapoor
US Stocks Higher; Dow Jumps 250 Points
- NewsVandana Singh
FDA Lifts Hold On GH Research's Depression Drug Trial After Two Years
- NewsRishabh Mishra
Stock Market Today: S&P 500, Nasdaq, WTI Crude Futures Advance After US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus (UPDATED)
- NewsAvi Kapoor
NextEra Energy, GH Research And 3 Stocks To Watch Heading Into Monday
- NewsAvi Kapoor
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
- News
'Psychedelics Proponents Hope Trump Administration Will Foster A New Era' - STAT News
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- NewsAvi Kapoor
Crude Oil Moves Higher; Owens & Minor Shares Plummet
- NewsAvi Kapoor
Dow Falls 150 Points; ISM Manufacturing PMI Rises In January
- NewsVandana Singh
Why Is GH Research Stock Trading Higher On Monday?
- NewsAvi Kapoor
S&P 500 Down Over 1%; Tyson Foods Posts Upbeat Results
- News
Market-Moving News for February 3rd
- NewsJelena Martinovic
Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.